BACKGROUND AND PURPOSE: We investigated whether soluble CD40L (sCD40L) may predict the risk of cardiovascular (CV) events in patients with asymptomatic carotid plaques. METHODS: Forty-two patients with asymptomatic low-grade carotid stenosis (ALCS) and 21 controls without any carotid stenosis were enrolled. All subjects had at least a major cardiovascular risk factor (CRF). Plasma levels of C-reactive protein (CRP), IL-6, and sCD40L were measured. Subjects were reviewed every 12 months (median follow-up, 8 years). RESULTS: ALCS patients had higher (P<0.0001) CRP, IL-6, and sCD40L than controls. Fourteen patients experienced a CV event. Cox regression analysis showed that only high sCD40L levels (P=0.003) independently predicted cardiovascular risk. CONCLUSIONS: High levels of sCD40L may predict the risk of CV events in ALCS.
|Data di pubblicazione:||2005|
|Titolo:||Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis|
|Autori:||NOVO S; BASILI S; TANTILLO R; FALCO A; DAVI V; NOVO G; CORRADO E; BARBAGALLO C; DAVI G|
|Tipologia:||Articolo su rivista|
|Citazione:||NOVO S, BASILI S, TANTILLO R, FALCO A, DAVI V, NOVO G, et al. (2005). Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis. STROKE, 36, 673-675.|
|Appare nelle tipologie:||01 - Articolo su rivista|